ESC 365 - The burden of structural heart valve diseases - Incidence, Prevalence, Treatment Pathways, Quality of Care in the EU.

Open Access

The burden of structural heart valve diseases - Incidence, Prevalence, Treatment Pathways, Quality of Care in the EU.

Session: Current minimally-invasive treatment modalities for heart valve diseases : what is next?

Topic: Treatment

Speaker: Professor B. Prendergast (London, GB)

Sponsored by Edwards Lifesciences

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Bernard David Prendergast

St Thomas', London (United Kingdom of Great Britain & Northern Ireland)

21 presentations

9 followers

5 more presentations in this session

Introduction and learning objective - Current minimally-invasive treatment modalities for heart valve diseases: what is next?

Speaker: Professor M. Gilard (Brest, FR)

What are current and future treatment modalities? A tailored approach - Aortic stenosis

Speaker: Professor H. Moellmann (Dortmund, DE)

What are current and future treatment modalities? A tailored approach - Mitral regurgitation

Speaker: Doctor A. Latib (New York, US)

What are current and future treatment modalities? A tailored approach - Tricuspid regurgitation

Speaker: Doctor M. Enriquez-Sarano (Minneapolis, US)

Session key takeaways - Current minimally-invasive treatment modalities for heart valve diseases : what is next?

Speaker: Professor M. Gilard (Brest, FR)

Access the full session

Current minimally-invasive treatment modalities for heart valve diseases : what is next?

Speakers: Professor B. Prendergast, Professor M. Gilard, Professor H. Moellmann, Doctor A. Latib, Doctor M. Enriquez-Sarano...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources